Newsroom

Sorted by: Latest

-

Voncierge Enters U.S. Market, Turning Airport Customer Service Into 24/7 Operational Infrastructure

LOS ANGELES--(BUSINESS WIRE)--Voncierge Enters U.S. Market, Turning Airport Customer Service Into 24/7 Operational Infrastructure...
-

Deepwatch Appoints Brian Dhatt as Chief Executive Officer to Lead its Next Phase as a Scaled Autonomous SOC Platform

PALO ALTO, Calif.--(BUSINESS WIRE)--Deepwatch, the leading autonomous SOC platform built on more than a decade of real-world security operations data, today announced the appointment of Brian Dhatt as Chief Executive Officer. Dhatt succeeds John DiLullo, who will remain with the company as an advisor. The company also announced the promotion of Chief Product and Technology Officer Anand Ramanathan to President, underscoring Deepwatch’s commitment to scaling its platform, accelerating product in...
-

Fathom Secures Strategic Investment From CVS Health Ventures to Accelerate Enterprise-Wide Autonomous Coding

SAN FRANCISCO--(BUSINESS WIRE)--Fathom has received a strategic investment from CVS Health Ventures, the venture capital arm of CVS Health....
-

First-of-Its-Kind Independent Study Finds FICO® Score 10T the Most Predictive Credit Score for Mortgage Lending

BOZEMAN, Mont.--(BUSINESS WIRE)--New white paper by Milliman shows FICO Score 10T outperforms VantageScore 4.0 on all mortgage types, including GSE and FHA loans....
-

Reproductive Endocrinologist and Former Jefferson-RMA Fellow Dr. Brent Hanson Joins RMA Northern California, Strengthening Fertility Care in the Region

SAN FRANCISCO--(BUSINESS WIRE)--IVI RMA North America, announced that Dr. Brent Hanson, an REI and former Jefferson-RMA fellow, has joined the RMA Northern California clinical team....
-

OpenEvidence and ACOG Announce Strategic Collaboration to Advance Ob-Gyn Health Care

MIAMI & WASHINGTON--(BUSINESS WIRE)--Today, OpenEvidence and American College of Obstetricians & Gynecologists (ACOG) announced a strategic collaboration to expand access to ACOG’s evidence-based clinical guidance and develop insights to help inform the future of ob-gyn care and women’s health. The collaboration brings together ACOG, the leading professional membership organization and author of clinical guidance for obstetrician–gynecologists, and OpenEvidence, the most widely used medical...
-

Deadline Soon: Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming May 5, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ: SLNO) common stock between March 26, 2025 and November 4, 2026, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON SOLENO THERAPEUTICS, INC. (SLNO), CLICK HERE TO PARTICIPATE...
-

ICAPE Group: Availability of the Preparatory Documents for the General Assembly of May 20, 2026

FONTENAY-AUX-ROSES, France--(BUSINESS WIRE)--Regulatory News: The ICAPE Group (ISIN code: FR001400A3Q3 – ticker symbol: ALICA), a global technology distributor of printed circuit boards (“PCB”) and custom electronic parts, announces the availability of the preparatory documents for the 2026 AGM. Shareholders of ICAPE Holding SA are invited to participate in the Combined General Meeting which will be held on Wednesday, May 20, 2026 at 8:30 a.m. (Paris time), at the registered office of the Compa...
-

Deadline Soon: Nektar Therapeutics (NKTR) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming May 5, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Nektar Therapeutics (“Nektar” or the “Company”) (NASDAQ: NKTR) securities between February 26, 2025 and December 15, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON NEKTAR THERAPEUTICS (NKTR), CLICK HERE TO PARTICIPATE IN THE SE...
-

Azelis: Transparantiekennisgeving Gimv Anchor Investments BV

ANTWERPEN, België--(BUSINESS WIRE)--Gereguleerde Informatie: In overeenstemming met artikel 14 van de Belgische Transparantiewet van 2 mei 2007 maakt Azelis Group NV (Brussels:AZE) bekend dat het op 29 april 2026 en 30 april 2026 transparantiekennisgevingen heeft ontvangen van Gimv Anchor Investments BV. 1. Samenvatting van de kennisgevingen In de kennisgeving gedateerd op 29 april 2026 heeft Gimv Anchor Investments BV gemeld dat op 23 april 2026, na een verwerving van effecten met stemrecht, G...